antibody-drug conjugates (adcs) in nsclc
Published 1 year ago • 422 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
2:26
exploring antibody-drug conjugates (adcs) in lung cancer
-
3:58
antibody drug conjugates in lung cancer
-
1:24
adcs in lung cancer treatment
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
1:49
adcs for lung cancer
-
3:23
antibody-drug conjugates in the treatment of solid tumors
-
1:25
targeting egfr-positive nsclc with antibody-drug conjugates
-
1:42
what are antibody drug conjugates (adcs)?
-
1:28:28
adc药物的研发历史、进展及挑战
-
4:18
antibody conjugates: what you need to know | cst tech tips
-
10:11
a brief introduction of antibody drug conjugate - creative biolabs
-
1:59
developments in adcs for nsclc
-
1:47
combining adcs with other treatment modalities in nsclc
-
2:07
emerging toxicities associated with adcs
-
0:46
antibody-drug conjugates in gynecological cancers
-
1:44
what are antibody-drug conjugates and how do they work against cancer?
-
2:50
adc’s for the treatment of nsclc
-
1:32
antibody-drug conjugates in urothelial carcinoma
-
2:30
the future of antibody-drug conjugates in urothelial cancer
-
13:18
updates in the management of lung cancer with adcs
-
1:35
challenges in development and clinical use of adcs for lung cancer
-
7:06
new hope in cancer treatment! what are antibody-drug conjugates (adcs)